Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel)
Willem, L; Xiao, L; Antillon, M; Bilcke, J; Jit, M
and Beutels, P
(2020).
Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel).
[Dataset].
Zenodo.
http://doi.org/10.5281/zenodo.3663447
and Beutels, P
(2020).
Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel).
[Dataset].
Zenodo.
http://doi.org/10.5281/zenodo.3663447
The objective of McMarcel is to evaluate the impact and cost-effectiveness of potential maternal and neonatal RSV immunisation strategies in 72 Gavi countries. The acronym stands for Multi-Country Model Application for RSV Cost-Effectiveness poLicy (McMarcel). If you use (parts of) this modelling project, please cite: Li, Willem, Antillon, Bilcke, Jit, Beutels. Health and economic burden of Respiratory Syncytial Virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries. BMC Medicine. (2020).
Keywords
Infectious diseases modelling; Cost-effectiveness analysis| Item Type | Dataset |
|---|---|
| Resource Type |
Resource Type Resource Description Software R script |
| Capture method | Other |
| Date | 12 February 2020 |
| Language(s) of written materials | English |
| Creator(s) |
Willem, L; Xiao, L; Antillon, M; Bilcke, J; Jit, M and Beutels, P
|
| LSHTM Faculty/Department | Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology (-2023) |
| Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom |
| Date Deposited | 18 Feb 2020 14:07 |
| Last Modified | 16 Sep 2021 09:15 |
| Publisher | Zenodo |
No files available. Please consult associated links.
